Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-16-093874
Filing Date
2016-09-21
Accepted
2016-09-21 16:42:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 113271
  Complete submission text file 0000000000-16-093874.txt   156809
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filed for) CIK: 0001018735 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances